Nukkleus Inc. Files 8-K on Key Agreements and Acquisitions

Ticker: DFNSW · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1787518

Sentiment: neutral

Topics: material-agreement, acquisition, financial-obligation, equity-sale

Related Tickers: NUKK

TL;DR

Nukkleus Inc. dropped an 8-K detailing new deals, acquisitions, and debt – big moves ahead!

AI Summary

On December 30, 2025, Nukkleus Inc. reported on several significant events. These include entering into a material definitive agreement, completing an acquisition or disposition of assets, creating a direct financial obligation, and unregistered sales of equity securities. The company also filed financial statements and exhibits related to these events.

Why It Matters

This 8-K filing indicates significant corporate actions by Nukkleus Inc., including potential acquisitions and new financial obligations, which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — The filing details material definitive agreements, acquisitions, and financial obligations, which inherently carry risks related to integration, financing, and market reception.

Key Players & Entities

FAQ

What specific material definitive agreement did Nukkleus Inc. enter into?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What was the nature of the acquisition or disposition of assets?

The filing states that there was a completion of an acquisition or disposition of assets, but the specifics of the assets involved or the transaction details are not detailed in the provided text.

What is the direct financial obligation created by Nukkleus Inc.?

The report mentions the creation of a direct financial obligation, but the nature and amount of this obligation are not specified in the provided text.

What were the details of the unregistered sales of equity securities?

The filing notes unregistered sales of equity securities, but the quantity, price, and terms of these sales are not disclosed in the provided text.

What is the business address and phone number for Nukkleus Inc.?

Nukkleus Inc.'s business address is 575 Fifth Avenue, 14th Floor, New York, NY 10017, and their business phone number is 212-791-4663.

Filing Stats: 2,128 words · 9 min read · ~7 pages · Grade level 10.9 · Accepted 2025-12-30 11:08:26

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. As previously reported on a Current Report on Form 8-K filed with the Securities and Exchange Commission on September 2, 2025, Nukkleus Inc., a Delaware corporation (the "Company"), entered into a Stock Purchase Agreement (the "Original Agreement") with its wholly owned Israeli subsidiary, Nukk Picolo Ltd. ("Nukk Picolo"), Tiltan Software Engineering Ltd., an Israeli corporation ("Tiltan"), and Arie Shafir (the "Seller"), pursuant to which, upon satisfaction of certain closing conditions, the Company would acquire all of the issued and outstanding shares of Tiltan from the Seller. Other than the Purchase Agreement, there is no material relationship between the Company or its affiliates and Tiltan or the Seller. On December 30, 2025, the Company, Nukk Picolo, Tiltan and the Seller entered into an Amendment to the Stock Purchase Agreement (the "Amendment", and together with the Original Agreement, the "Purchase Agreement") confirming that the consummation of the acquisition is on said date. The terms of the Amendment also provided that (i) the initial cash payment to be paid on December 31, 2025 shall be paid in U.S. Dollars based on the exchange rate published by the Bank of Israel on December 31 st and (ii) the Seller would be subject to non-competition and non-solicitation covenants beginning at closing and ending June 2027. The Amendment also provides that the pre-closing dividend in the amount of NIS 3,236,088 for the year ended December 31, 2025, payable by Tiltan to the Seller pursuant to the terms of the Original Agreement, shall be paid by the Company during the 2026 calendar year from payments made from select customers, Except as specifically amended by the Amendment, all of the other terms of the Original Agreement remained in full force and effect. The information set forth under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.

01 Completion of Acquisition or Disposition of Assets

Item 2.01 Completion of Acquisition or Disposition of Assets. Reference is made to the disclosure set forth under Item 1.01 above, which is incorporated herein by reference. On December 30, 2025, the Company and Nukk Picolo consummated the acquisition of all the issued and outstanding stock of Tiltan in consideration of NIS 47,600,000 (approximately $14,000,000). The purchase price is payable in a combination of (i) cash equal to 75% of the purchase price (the "Cash Portion"), or NIS 35,700,000 (approximately $10,500,000), a portion of which (NIS 5,283,333, less NIS 666,667 retained by the Company as working capital for Tiltan) will be paid by the Company to the Seller and the remainder of which is evidenced by the Note (as defined herein) delivered at closing, and (ii) shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), equal to 25% of the purchase price (the "Stock Portion"), or NIS 11,900,000 (approximately $3,500,000). As a result of the acquisition, Tiltan became an indirect wholly owned subsidiary of the Company. 1 Cash Portion The remaining Cash Portion of NIS 29,750,000 (approximately $8,750,000) is payable by the Company in five installments at 36-day intervals until the final payment on June 29, 2026, with the first two installments each being reduced by NIS 666,667 for working capital to be retained by Tiltan. The cash payments are evidenced by the Note and secured by the pledge described below. Stock Portion At closing, the Company deposited into escrow with Adv. Lior Hinkus, as escrow agent, 2,000,000 shares of Common Stock. The Original Agreement provided for the escrow of shares of Common Stock having an aggregate value equal to 50% of the total purchase price (NIS 23,800,000), calculated based on the market price of the Common Stock on December 30, 2025 (the "Escrowed Shares"). On June 29, 2026, the escrow agent shall release to the Seller shares of Common Stock having an aggregate value equal to 25% of the

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Items 1.01 and 2.01 above, including the descriptions of the Note and the Pledge Agreement, is incorporated herein by reference.

02

Item 3.02 Unregistered Sale of Equity Securities. Reference is made to the disclosure set forth under Items 1.01 and 2.01 above, which disclosure is incorporated herein by reference. At closing, the Company issued 2,000,000 shares of Common Stock to the escrow agent (the "Escrowed Shares"). The issuance of the Escrowed Shares was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), as transactions by an issuer not involving any public offering. The Seller represented that he is a sophisticated investor and had access to information concerning the Company. The securities were issued without general solicitation or advertising. The securities are restricted securities for purposes of the Securities Act and the certificates representing such shares bear restrictive legends to that effect. 3 Item 8.01 Other Events. On December 30, 2025, the Company issued a press release announcing the closing of the Acquisition. A copy of the press release is attached as Exhibit 99.3 to this Current Report on Form 8-K and is incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding the Company's expectations, intentions, and strategies regarding the future, including the anticipated benefits of the acquisition and the timing of future payments. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those anticipated because of various factors, including those described in the Company's filings with the Securities and Exchange Commission, including its Registration Statements on Form S-1 filed with the SEC. The Company undertakes no obligation to update any forward-looking Item 9.01 Financial Statements and Exhibits. (a) Financial Statements of Business Acquired. In accordance with Item 9.01(a), the audited financial this Current Report on Form 8-K and are incorporated herein by reference. In accordance with Item 9.01(a), the unaudited condensed financial statements of Tiltan for the nine months ended September 30, 2025 are attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and are incorporated herein by reference. (b) Pro Forma Financial Information. The unaudited pro forma condensed combined financial information required by this Item 9.01(b) is not included with this Current Report on Form 8-K and will be filed by amendment no later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed. (d) Exhibits. Exhibit No. Description 4.1* Secu

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: December 30, 2025 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 5

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing